Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL
Amrita V. Kamath, Jian Wang, Francis Y. Lee, Punit H. MaratheVolume:
61
Language:
english
Pages:
12
DOI:
10.1007/s00280-007-0478-8
Date:
March, 2008
File:
PDF, 341 KB
english, 2008